AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2663165 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam 0.5% gel
Number of subjects: 173
Study 2663165 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac 1.16% gel
Number of subjects: 173
Study 31980016 — intervention group
Group type: EXPERIMENTAL
Intervention: ECOPIH users in the consolidation phase
Number of subjects: 289
Study 31980016 — intervention group
Group type: EXPERIMENTAL
Intervention: ECOPIH users
Number of subjects: 289
Study 31068954 — intervention group
Group type: EXPERIMENTAL
Intervention: COBRA therapy (prednisone 60 mg, methotrexate, sulfasalazine), n = 14
Number of subjects: 35
Study 31068954 — intervention group
Group type: COMPARATOR
Intervention: COBRA-light therapy (prednisone 30 mg, methotrexate), n = 21
Number of subjects: 35
Study 27353246 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise group
Number of subjects: 66
Study 27353246 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise group
Number of subjects: 66
Study 27353246 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study 25986785 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human thrombopoietin
Number of subjects: 708
Study 25986785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 708
Study 23507685 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine mouthwash (SRP/CHX Gr‐1)
Number of subjects: 30
Study 23507685 — intervention group
Group type: COMPARATOR
Intervention: Curcumin mouthwash (SRP/CUR Gr‐2)
Number of subjects: 30
Study 23507685 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP Gr‐3)
Number of subjects: 30
Study 20696480 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led intervention for treating depression
Number of subjects: 121
Study 20696480 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behaviour therapy (CBT) for preventing depression
Number of subjects: 121
Study 20696480 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 121
Study 19246907 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 10 mg/day
Number of subjects: 189
Study 17523274 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) group
Number of subjects: 72
Study 17523274 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard evaluation by consultant surgeon)
Number of subjects: 72
Study 12701940 — intervention group
Group type: COMPARATOR
Intervention: Daily rhDNase
Number of subjects: 40
Study 12701940 — intervention group
Group type: COMPARATOR
Intervention: Alternate day rhDNase
Number of subjects: 40
Study 11171465 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (target dose 5 micrograms.ml‐1 in 5 min)
Number of subjects: 26
Study 11171465 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (8% tidal volume)
Number of subjects: 26
Study 9172022 — intervention group
Group type: EXPERIMENTAL
Intervention: Ohmeda and Nellcor N200 with finger probe
Number of subjects: 8
Study 9172022 — intervention group
Group type: EXPERIMENTAL
Intervention: Nellcor N200 with finger probe and N200 with C lock
Number of subjects: 8
Study 9172022 — intervention group
Group type: EXPERIMENTAL
Intervention: Nellcor N200 with finger probe and Nellcor C Lock
Number of subjects: 8
Study 9172022 — intervention group
Group type: EXPERIMENTAL
Intervention: Criticare oximeter
Number of subjects: 8
Study 7682268 — intervention group
Group type: EXPERIMENTAL
Intervention: Talc insufflation under thoracoscopic guidance
Number of subjects: 124
Study 7682268 — intervention group
Group type: COMPARATOR
Intervention: Bleomycin
Number of subjects: 124
Study 7682268 — intervention group
Group type: COMPARATOR
Intervention: Tetracycline
Number of subjects: 124
Study 3467975 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg
Number of subjects: 12
Study 3467975 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 40 mg
Number of subjects: 12
Study 3467975 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg
Number of subjects: 12
Study 3467975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3467975 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 40 mg (9 nights)
Number of subjects: 12
Study 3467975 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 75 mg (9 nights)
Number of subjects: 12
Study 3467975 — intervention group
Group type: COMPARATOR
Intervention: Placebo (9 nights)
Number of subjects: 12
Study 29966024 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active)
Number of subjects: 41
Study 29966024 — intervention group
Group type: COMPARATOR
Intervention: Extensively hydrolyzed whey-based formula without short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (control)
Number of subjects: 41
Study 27425567 — intervention group
Group type: EXPERIMENTAL
Intervention: Maytiv positive psychology school program
Number of subjects: 2517
Study 27425567 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2517
Study 25498035 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial approach (TRA)
Number of subjects: 49
Study 25498035 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral approach (TFA)
Number of subjects: 49
Study 22402304 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 72
Study 22402304 — intervention group
Group type: COMPARATOR
Intervention: Refraining from chewing gum
Number of subjects: 72
Study 20580541 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose arachidonic acid (80 mg ARA daily for 3 weeks)
Number of subjects: 23
Study 20580541 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 23
Study 17981455 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac and paracetamol
Number of subjects: 78
Study 17981455 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol alone
Number of subjects: 78
Study 17981455 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac alone
Number of subjects: 78
Study 16020567 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation program
Number of subjects: 64
Study 16020567 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 64
Study 14725499 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (parent absent)
Number of subjects: 200
Study 14725499 — intervention group
Group type: COMPARATOR
Intervention: Group II (parent present)
Number of subjects: 200
Study 10546925 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 8
Study 10546925 — intervention group
Group type: COMPARATOR
Intervention: Artemether with water
Number of subjects: 8
Study 8740720 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine 30 mg/m2 followed by Taxol 120 mg/m2 (V/T sequence)
Number of subjects: 15
Study 8740720 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxol 120 mg/m2 followed by Vinorelbine 30 mg/m2 (T/V sequence)
Number of subjects: 15
Study 1930697 — intervention group
Group type: EXPERIMENTAL
Intervention: Plak Trac toothbrush
Number of subjects: 0
Study 1930697 — intervention group
Group type: COMPARATOR
Intervention: Colgate ADA-approved manual toothbrush
Number of subjects: 0
Study 1930697 — intervention group
Group type: COMPARATOR
Intervention: Interplak toothbrush
Number of subjects: 0
Study 1930697 — intervention group
Group type: COMPARATOR
Intervention: Oral B 35 manual brush
Number of subjects: 0
Study 6127945 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (240 mg/day)
Number of subjects: 22
Study 6127945 — intervention group
Group type: COMPARATOR
Intervention: Verapamil (360 mg/day)
Number of subjects: 22
Study 6127945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 31521553 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist advice and booklet about staying active during hospitalisation
Number of subjects: 68
Study 31521553 — intervention group
Group type: COMPARATOR
Intervention: Usual hospital care
Number of subjects: 68
Study 29728394 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined CETP concentration increase of 1 µg/mL
Number of subjects: 5706
Study 26350543 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine (81 patients)
Number of subjects: 178
Study 26350543 — intervention group
Group type: COMPARATOR
Intervention: Control (97 patients)
Number of subjects: 178
Study 24473774 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-risk acute lymphoblastic leukemia (SR-ALL) therapy
Number of subjects: 159
Study 22496114 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1800
Study 22496114 — intervention group
Group type: COMPARATOR
Intervention: PCI
Number of subjects: 1800
Study 19946860 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 66
Study 19946860 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 66
Study 19946860 — intervention group
Group type: COMPARATOR
Intervention: Depot form of pre-randomisation drug
Number of subjects: 66
Study 17877593 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 17
Study 17877593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 16244022 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-dose (SD) bupivacaine (7.5 mg) with 5 mug of sufentanil
Number of subjects: 38
Study 16244022 — intervention group
Group type: COMPARATOR
Intervention: Large-dose (LD) bupivacaine (12.5 mg) with 5 mug of sufentanil
Number of subjects: 38
Study 12912857 — intervention group
Group type: EXPERIMENTAL
Intervention: Satiety drinking test in severely dyspeptic patients
Number of subjects: 62
Study 12912857 — intervention group
Group type: COMPARATOR
Intervention: Satiety drinking test in controls
Number of subjects: 62
Study 12912857 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological agents (sumatriptan, cisapride, erythromycin)
Number of subjects: 62
Study 12912857 — intervention group
Group type: EXPERIMENTAL
Intervention: Satiety drinking test overall
Number of subjects: 62
Study 10680107 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium 0.05 mg/kg (ED95)
Number of subjects: 40
Study 10680107 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium 0.1 mg/kg (2 x ED95)
Number of subjects: 40
Study 10680107 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium 0.025 mg/kg (0.5 x ED95)
Number of subjects: 40
Study 8765865 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 ml 0.5% bupivacaine + 0.1 mg fentanyl (B+F group)
Number of subjects: 43
Study 8765865 — intervention group
Group type: COMPARATOR
Intervention: 8 ml 0.5% bupivacaine + 2 ml saline (Bup group)
Number of subjects: 43
Study 1658407 — intervention group
Group type: EXPERIMENTAL
Intervention: NDP (Nle4D-Phe7) alpha-MSH
Number of subjects: 28
Study 1658407 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 28
Study 7202950 — intervention group
Group type: COMPARATOR
Intervention: Pneumatic forceful dilatation
Number of subjects: 38
Study 7202950 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical esophagomyotomy
Number of subjects: 38
Study 31863758 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased end of surgery to baseline ratio of neuroserpin
Number of subjects: 100
Study 31863758 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrations of neuroserpin
Number of subjects: 100
Study 31863758 — intervention group
Group type: EXPERIMENTAL
Intervention: Glial fibrillary acidic protein, phosphorylated axonal neurofilament subunit H, and visinin-like protein 1
Number of subjects: 100
Study 30925948 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-dose ropivacaine hydrochloride (1 mL) combined with fentanyl (10 µg)
Number of subjects: 134
Study 30925948 — intervention group
Group type: COMPARATOR
Intervention: Large-dose ropivacaine hydrochloride (1.5 mL)
Number of subjects: 134
Study 30925948 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-dose ropivacaine hydrochloride combined with fentanyl
Number of subjects: 134
Study 28493623 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (15 mg over 8 days)
Number of subjects: 99
Study 28493623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 26408488 — intervention group
Group type: EXPERIMENTAL
Intervention: Video version of the Web-based computer-tailored obesity prevention intervention
Number of subjects: 1419
Study 26408488 — intervention group
Group type: COMPARATOR
Intervention: Text version of the Web-based computer-tailored obesity prevention intervention
Number of subjects: 1419
Study 26408488 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based computer-tailored obesity prevention intervention (both video and text)
Number of subjects: 1419
Study 26408488 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based computer-tailored obesity prevention intervention
Number of subjects: 1419
Study 22446565 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir (1.5 g twice daily for 18 weeks)
Number of subjects: 24
Study 22446565 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 22554310 — intervention group
Group type: EXPERIMENTAL
Intervention: Teachable Moments Communication Process (TMCP) intervention for smoking cessation
Number of subjects: 840
Study 22554310 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention
Number of subjects: 840
Study 20017356 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 100 mg daily for 30 days
Number of subjects: 80
Study 20017356 — intervention group
Group type: COMPARATOR
Intervention: Nimesulide 100 mg BID for 30 days
Number of subjects: 80
Study 17415683 — intervention group
Group type: EXPERIMENTAL
Intervention: US preference weights
Number of subjects: 1126
Study 17415683 — intervention group
Group type: COMPARATOR
Intervention: UK preference weights
Number of subjects: 1126
Study 17415683 — intervention group
Group type: EXPERIMENTAL
Intervention: US and UK preference weights
Number of subjects: 1126
Study 11199242 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia program in Dalby
Number of subjects: 800
Study 11199242 — intervention group
Group type: COMPARATOR
Intervention: Control group in S Sandby
Number of subjects: 800
Study 8689337 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ceftriaxone followed by oral cefixime
Number of subjects: 80
Study 1620430 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ev type anesthesia (AEC) using propofol
Number of subjects: 0
Study 1620430 — intervention group
Group type: COMPARATOR
Intervention: Balanced anesthesia (AB)
Number of subjects: 0
Study 6366811 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinary metoprolol tablets (100 mg twice daily)
Number of subjects: 10
Study 6366811 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release metoprolol tablets (200 mg once daily)
Number of subjects: 10
Study 30415084 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime ambulatory blood pressure monitoring
Number of subjects: 80
Study 29852038 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib
Number of subjects: 0
Study 26716932 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT OPEN module
Number of subjects: 15
Study 26716932 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT ENGAGED module
Number of subjects: 15
Study 26716932 — intervention group
Group type: EXPERIMENTAL
Intervention: Both modules
Number of subjects: 15
Study 24418366 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (depression care management with treatment adherence support and interpersonal psychotherapy if desired)
Number of subjects: 417
Study 24418366 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 417
Study 22019201 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein meal (HiPro Fru meal) after hyper-energetic high fructose diet (HiFruD)
Number of subjects: 8
Study 22019201 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein meal (HiPro Fru meal) after hyper-energetic high fructose high protein diet (HiFruHiProD)
Number of subjects: 8
Study 22019201 — intervention group
Group type: COMPARATOR
Intervention: Low protein meal (Fru meal) after hyper-energetic high fructose diet (HiFruD)
Number of subjects: 8
Study 22019201 — intervention group
Group type: COMPARATOR
Intervention: Low protein meal (Fru meal) after hyper-energetic high fructose high protein diet (HiFruHiProD)
Number of subjects: 8
Study 20471273 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapeutic group training including gait and balance exercises with function-oriented strengthening (N=35)
Number of subjects: 71
Study 20471273 — intervention group
Group type: COMPARATOR
Intervention: Control group (N=36)
Number of subjects: 71
Study 17117432 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding jejunostomy
Number of subjects: 150
Study 17117432 — intervention group
Group type: COMPARATOR
Intervention: Nasoduodenal tube
Number of subjects: 150
Study 16260510 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy (daily oral conjugated estrogen 0.625 mg plus medroxyprogesterone acetate 2.5 mg)
Number of subjects: 1208
Study 16260510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1208
Study 16260510 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy
Number of subjects: 1208
Study 12099947 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-held record (PHR)
Number of subjects: 100
Study 12099947 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PHR)
Number of subjects: 100
Study 12099947 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary healthcare (PHC) professionals
Number of subjects: 100
Study 9988782 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dose nutritional formula (Myer's Cocktail)
Number of subjects: 64
Study 9988782 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose nutritional I/V
Number of subjects: 64
Study 9988782 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 64
Study 7568735 — intervention group
Group type: EXPERIMENTAL
Intervention: Periotest method
Number of subjects: 0
Study 2405610 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine
Number of subjects: 39
Study 2405610 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine triphosphate (ATP)
Number of subjects: 39
Study 31273529 — intervention group
Group type: EXPERIMENTAL
Intervention: Lined with resin‐modified glass ionomer (RMGIC)
Number of subjects: 39
Study 31273529 — intervention group
Group type: COMPARATOR
Intervention: Unlined cavities
Number of subjects: 39
Study 31273529 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lined and unlined restorations
Number of subjects: 39
Study 30851166 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day sequential therapy (esomeprazole 40 mg, amoxicillin 1 g for 5 days, followed by esomeprazole 40 mg, clarithromycin 500 mg, and tinidazole 500 mg for 5 days)
Number of subjects: 291
Study 30851166 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day sequential therapy (esomeprazole 40 mg, amoxicillin 1 g for 7 days, followed by esomeprazole 40 mg, clarithromycin 500 mg, and tinidazole 500 mg for 7 days)
Number of subjects: 291
Study 27677565 — intervention group
Group type: EXPERIMENTAL
Intervention: MIE with CEA
Number of subjects: 356
Study 27677565 — intervention group
Group type: EXPERIMENTAL
Intervention: MIE with IEA
Number of subjects: 356
Study 25329822 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (100 μg)
Number of subjects: 100
Study 25329822 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 100
Study 23828423 — intervention group
Group type: EXPERIMENTAL
Intervention: Endouterine hemostatic square suture
Number of subjects: 13
Study 23828423 — intervention group
Group type: COMPARATOR
Intervention: Bakri balloon tamponade
Number of subjects: 13
Study 21846796 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyl selenocysteine, single-dose, pharmacokinetics
Number of subjects: 0
Study 21846796 — intervention group
Group type: COMPARATOR
Intervention: Selenomethionine, 200 μg per day
Number of subjects: 0
Study 21846796 — intervention group
Group type: COMPARATOR
Intervention: Selenized yeast (NPC agent)
Number of subjects: 0
Study 20484768 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual visuo-proprioceptive practice
Number of subjects: 0
Study 20484768 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuo-proprioceptive imagery practice
Number of subjects: 0
Study 17014927 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography for detecting endotracheal tube placement
Number of subjects: 33
Study 16368046 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day
Number of subjects: 7705
Study 16368046 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 120 mg/day
Number of subjects: 7705
Study 16368046 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (pooled groups)
Number of subjects: 7705
Study 16368046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7705
Study 11812709 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air warming
Number of subjects: 30
Study 11812709 — intervention group
Group type: COMPARATOR
Intervention: Passive insulation
Number of subjects: 30
Study 9814500 — intervention group
Group type: EXPERIMENTAL
Intervention: CRH‐R1 mRNA in the LS
Number of subjects: 0
Study 9814500 — intervention group
Group type: EXPERIMENTAL
Intervention: CRH‐R2 mRNA in the LS
Number of subjects: 0
Study 9814500 — intervention group
Group type: EXPERIMENTAL
Intervention: CRH‐R1 and CRH‐R2 protein localization
Number of subjects: 0
Study 9814500 — intervention group
Group type: EXPERIMENTAL
Intervention: CRH‐R1 mRNA presence
Number of subjects: 0
Study 9814500 — intervention group
Group type: EXPERIMENTAL
Intervention: CRH‐R2 mRNA presence
Number of subjects: 0
Study 7699607 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic toothbrush
Number of subjects: 0
Study 7699607 — intervention group
Group type: COMPARATOR
Intervention: Conventional toothbrush
Number of subjects: 0
Study 2560284 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (E), 10 mg/day for four weeks
Number of subjects: 22
Study 2560284 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 22
Study 203308 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 0